SCS
ORIC icon

Sound Capital Solutions’s Oric Pharmaceuticals ORIC Stock Holding History

Sound Capital Solutions’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Buy
+32,216
New +$292K 0.08% 251

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIHC Capital Management Central $104M AUM
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return

Sound Capital Solutions's ORIC Position: Q2 2026 in Review

Sound Capital Solutions opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 32,216 shares worth $349K. The stake represents 0.08% of the portfolio and ranks #251 among its holdings.

163 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Sound Capital Solutions held 32,216 shares of Oric Pharmaceuticals worth $349K as of Q2 2026.
  • Oric Pharmaceuticals was a new Sound Capital Solutions position in Q2 2026.
  • Oric Pharmaceuticals made up 0.08% of Sound Capital Solutions's portfolio in Q2 2026, its #251 holding.
  • 163 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Sound Capital Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.